A canonical problem in computer science is to find the shortest route to every point in a network. A new approach beats the classic algorithm taught in textbooks.

Recursion Pharmaceuticals is expected to provide updates regarding the clinical-stage pipeline programs on its second-quarter earnings call.

In July 2025, Recursion Pharmaceuticals acquired Rallybio’s full stake in their joint venture for developing REV102 and an associated backup molecule for the treatment of hypophosphatasia.

Here’s How Most Adults Are Using AI in the U.S. Right Now A recent poll reveals some clear ways that people are tapping into the power of AI.

Precision-designed using Recursion’s generative AI and active learning platform to optimize for non-covalent binding and ADME/PK, potentially delivering a broader therapeutic window, reduced off ...

In July 2025, Recursion Pharmaceuticals acquired Rallybio’s full stake in their joint venture for developing REV102 and an associated backup molecule for the treatment of hypophosphatasia. REV102, a ...

What’s on offer? Fat Phill’s is a Dutch-born burger franchise that opened in Temple Bar, Dublin, in May, bringing with it the kind of American-style fast food that’s built for the algorithm ...

Investors weren't cheered by news from one of the biotech's rivals. Clinical-stage biotech Recursion Pharmaceuticals ' (RXRX -4.66%) stock took it on the chin in the first trading day of the week.